[1]
2019. Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S22. DOI:https://doi.org/10.25251/skin.3.supp.22.